×
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT

Coronavirus news highlights: Delhi continues to post high Covid-19 numbers with 7,486 new cases, 131 deaths

India's Covid-19 caseload went past 89.4 lakh with 43,764 new cases and 545 deaths, while the number of people who have recovered from the disease surged past 83.7 lakh. More than a quarter million people have died from Covid-19 in the United States, the Johns Hopkins University tally recorded. Stay tuned on DH for more latest updates.
Last Updated 18 November 2020, 23:30 IST
17:5418 Nov 2020

7,486 new positive cases 6,901 recoveries and 131 deaths reported in Delhi in the last 24 hours The total number of #COVID19 cases in Delhi stands at 5,03,084 including 42,458 active cases, 4,52,683 recoveries and 7,943 deaths

15:3118 Nov 2020

Maharashtra reports 5,011 new Covid-19 cases, 6,608 recoveries & 100 deaths today. The total number of cases in the state is 17,57,520 There are 80,221 active cases in the State and 16,30,111 patients have recovered so far. The death toll is at 46,202.

15:2918 Nov 2020

Mumbai reports 871 new Covid-19 cases, 1372 recoveries/discharges and 16 deaths today. Total cases here rise to 2,71,525, including 2,48,711 recoveries/discharges and 10,612 deaths.

People crowd along a road in a shopping areaamid the Covid-19coronaviruspandemic inMumbai. Credit: AFP File Photo

15:2718 Nov 2020

Mysteries of Covid-19 smell loss finally yield some answers

An estimated 80 per cent of people with Covid-19 have smell disturbances, and many also have dysgeusia or ageusia (a disruption or loss of taste, respectively) or changes in chemesthesis (the ability to sense chemical irritants such as hot chilies). Smell loss is so common in people with the disease that some researchers have recommended its use as a diagnostic test because it may be a more reliable marker than fever or other symptoms.

Read more

15:2518 Nov 2020

Phase 3 trial of Covaxin to begin in Haryana on November 20, Anil Vij offers to be first volunteer

Covaxin is being developed indigenously by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR).

Last month, the vaccine maker had said it had successfully completed the interim analysis of Phase 1 and 2 trials and is initiating Phase 3 trials.

Read more

(Published 18 November 2020, 01:46 IST)

Follow us on